Cargando…

Prostate-specific antigen density as a parameter for the prediction of positive lymph nodes at radical prostatectomy

OBJECTIVE: The aim was to determine the prognostic ability of Partin's tables for a patient collective undergoing radical prostatectomy (RP) and to evaluate the association of prostate-specific antigen (PSA) density (PSAD) and postoperative lymph node status. METHODS: From 1999 to 2006, 393 con...

Descripción completa

Detalles Bibliográficos
Autores principales:	Yiakoumos, Theocharis, Kälble, Tilman, Rausch, Steffen
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Medknow Publications & Media Pvt Ltd 2015
Materias:	Original Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4660691/ https://www.ncbi.nlm.nih.gov/pubmed/26692660 http://dx.doi.org/10.4103/0974-7796.152118

Ejemplares similares

Radical Prostatectomy: An Option for High-Risk Prostate Cancer
por: Rausch, S., et al.
Publicado: (2012)

The Role of Radical Prostatectomy and Lymph Node Dissection in Clinically Node Positive Patients
por: Motterle, Giovanni, et al.
Publicado: (2019)

Prostate specific antigen (PSA) persistence 6 weeks after radical prostatectomy and pelvic lymph node dissection as predictive factor of radiographic progression in node-positive prostate cancer patients
por: Kim, Jung Kwon, et al.
Publicado: (2019)

Clinical outcomes of salvage treatment in lymph node-positive prostate cancer patients after radical prostatectomy
por: Kim, Dowook, et al.
Publicado: (2021)

Current Status and Future Perspective on the Management of Lymph Node-Positive Prostate Cancer after Radical Prostatectomy
por: Shiota, Masaki, et al.
Publicado: (2022)

Characterization of Lymph Node Tumor Burden in Node-Positive Prostate Cancer Patients after Robotic-Assisted Radical Prostatectomy with Extended Pelvic Lymph Node Dissection
por: Gottlieb, Josh, et al.
Publicado: (2023)

Eliminating microscopic lymph node metastasis by performing pelvic lymph node dissection during radical prostatectomy for prostate cancer
por: Furubayashi, Nobuki, et al.
Publicado: (2020)

Lymph swelling after radical prostatectomy and pelvic lymph node dissection
por: Carlsson, Stefan, et al.
Publicado: (2022)

Predictive Value of Positive Surgical Margins after Radical Prostatectomy for Lymph Node Metastasis in Locally Advanced Prostate Carcinoma
por: Otto, Wolfgang, et al.
Publicado: (2012)

Robotic Salvage Lymph Node Dissection After Radical Prostatectomy
por: Torricelli, Fabio C. M., et al.
Publicado: (2015)

Oncologic Outcomes of Lymph Node Dissection at Salvage Radical Prostatectomy
por: Preisser, Felix, et al.
Publicado: (2023)

The role of lymph node dissection in salvage radical prostatectomy for patients with radiation recurrent prostate cancer
por: Quhal, Fahad, et al.
Publicado: (2021)

Impact of Lymph Node Burden on Survival of High-risk Prostate Cancer Patients Following Radical Prostatectomy and Pelvic Lymph Node Dissection
por: Moris, Lisa, et al.
Publicado: (2016)

Distribution of prostate cancer recurrences on gallium‐68 prostate‐specific membrane antigen ((68)Ga‐PSMA) positron‐emission/computed tomography after radical prostatectomy with pathological node‐positive extended lymph node dissection
por: Huits, Thijs H., et al.
Publicado: (2020)

Extended lymph node dissection in robot-assisted radical prostatectomy: lymph node yield and distribution of metastases
por: Kim, Kwang Hyun, et al.
Publicado: (2014)

Pelvic Radiotherapy versus Radical Prostatectomy with Limited Lymph Node Sampling for High-Grade Prostate Adenocarcinoma
por: Baker, Christopher B., et al.
Publicado: (2016)

Extended lymph node dissection in robotic radical prostatectomy: Current status
por: Chopra, Sameer, et al.
Publicado: (2016)

Pelvic Lymph Node Dissection at the Time of Radical Prostatectomy: Extended? Of Course Not!
por: Sooriakumaran, Prasanna, et al.
Publicado: (2022)

Pelvic Lymph Node Dissection at the Time of Radical Prostatectomy: Extended, of Course
por: Gandaglia, Giorgio, et al.
Publicado: (2022)

Adjuvant Treatment Approaches after Radical Prostatectomy with Lymph Node Involvement
por: Tavukçu, Hasan Hüseyin, et al.
Publicado: (2022)

High body mass index predicts multiple prostate cancer lymph node metastases after radical prostatectomy and extended pelvic lymph node dissection
por: Porcaro, Antonio B, et al.
Publicado: (2019)

Endogenous testosterone density is an independent predictor of pelvic lymph node invasion in high-risk prostate cancer: results in 201 consecutive patients treated with radical prostatectomy and extended pelvic lymph node dissection
por: Porcaro, Antonio Benito, et al.
Publicado: (2022)

Does anterior prostatic fat tissue removed during robotic radical prostatectomy contain any lymph nodes?
por: Atmaca, Ali Fuat, et al.
Publicado: (2015)

KLK3 and TMPRSS2 for molecular lymph-node staging in prostate cancer patients undergoing radical prostatectomy
por: Lunger, Lukas, et al.
Publicado: (2020)

Developing a personalized template for lymph node dissection during radical prostatectomy
por: Pathak, Ram A., et al.
Publicado: (2018)

Evaluation of a genomic classifier in radical prostatectomy patients with lymph node metastasis
por: Lee, Hak J, et al.
Publicado: (2016)

Survival after radical prostatectomy versus radiation therapy in clinical node‐positive prostate cancer
por: Chierigo, Francesco, et al.
Publicado: (2022)

Prostate-Specific Antigen Density as a Powerful Predictor of Extracapsular Extension and Positive Surgical Margin in Radical Prostatectomy Patients with Prostate-Specific Antigen Levels of Less than 10 ng/ml
por: Chang, Jin-Seok, et al.
Publicado: (2011)

Lymph node ratio determines the benefit of adjuvant radiotherapy in pathologically 3 or less lymph node-positive prostate cancer after radical prostatectomy: a population-based analysis with propensity-score matching
por: Kim, Yi-Jun, et al.
Publicado: (2017)

The role of cytoreductive radical prostatectomy and lymph node dissection in bone‐metastatic prostate cancer: A population‐based study
por: Zhai, Tingshuai, et al.
Publicado: (2023)

Clinical value of extended pelvic lymph node dissection in patients subjected to radical prostatectomy
por: Dobruch, Jakub, et al.
Publicado: (2014)

Prevalence of Lymph Node Metastasis in Radical Prostatectomy; A Retrospective and Multicenter Study in Iran
por: Ayati, Mohsen, et al.
Publicado: (2014)

Laparoscopic radical prostatectomy and extended pelvic lymph node dissection: a combined technique
por: Jarzemski, Piotr, et al.
Publicado: (2020)

Pelvic Lymph Node Dissection at the Time of Radical Prostatectomy: Extended or Not. The Referee Point of View
por: Perera, Marlon, et al.
Publicado: (2022)

Predictive factors for lymph node positivity in patients undergoing extended pelvic lymphadenectomy during robot assisted radical prostatectomy
por: Batra, Vikram, et al.
Publicado: (2015)

Patients with Positive Lymph Nodes after Radical Prostatectomy and Pelvic Lymphadenectomy—Do We Know the Proper Way of Management?
por: Małkiewicz, Bartosz, et al.
Publicado: (2022)

Lymph node density as a surrogate marker for positive lymph nodes
por: Van Gorp, T, et al.
Publicado: (2011)

Identifying the Candidates Who Will Benefit From Extended Pelvic Lymph Node Dissection at Radical Prostatectomy Among Patients With Prostate Cancer
por: Yang, Guanjie, et al.
Publicado: (2022)

Influence of Biopsy Gleason Score on the Risk of Lymph Node Invasion in Patients With Intermediate-Risk Prostate Cancer Undergoing Radical Prostatectomy
por: Wenzel, Mike, et al.
Publicado: (2021)

Biochemical recurrence after radical prostatectomy according to nadir prostate specific antigen value
por: Chung, Jae Hoon, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_gq5q3hvke56nvgiv8e2jbn3oh7